CASONDRA BANKS: Open Payments
NPI 1679562136 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 49 payments from 10 companies in 2025. Trend: 2023 $220 · 2024 $614 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $315 |
| Regeneron Healthcare Solutions, Inc. | 6 | $143 |
| GENZYME CORPORATION | 4 | $107 |
| Janssen Biotech, Inc. | 6 | $106 |
| Galderma Laboratories, L.P. | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Lilly USA, LLC | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, NEMLUVIO, COSENTYX, EBGLYSS, Sotyktu.
Industry payments across FL — which companies pay providers there.
